Bridge City Capital’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.21M	Buy	54,874 +25,339	+86%	+$947K	0.61%	67
2025 Q4	$1.03M	Buy	29,535 +10,324	+54%	+$811K	0.3%	93
2025 Q3	$1.6M	Sell	19,211 -331	-2%	-$24K	0.43%	87
2025 Q2	$1.43M	Sell	19,542 -22,487	-54%	-$1.63M	0.4%	90
2025 Q1	$4.8M	Sell	42,029 -15,863	-27%	-$966K	1.44%	20
2024 Q4	$2.92M	Buy	57,892 +518	+0.9%	+$27.1K	0.78%	57
2024 Q3	$2.66M	Buy	57,374 +8,137	+17%	+$289K	0.73%	65
2024 Q2	$1.6M	Sell	49,237 -401	-0.8%	-$11K	0.54%	80
2024 Q1	$1.25M	Buy	49,638 +386	+0.8%	+$9.12K	0.46%	88
2023 Q4	$1.6M	Buy	49,252 +5,767	+13%	+$158K	0.62%	78
2023 Q3	$1.18M	Sell	43,485 -17,147	-28%	-$496K	0.6%	80
2023 Q2	$1.35M	Buy	60,632 +35	+0.1%	+$806	0.64%	74
2023 Q1	$1.31M	Sell	60,597 -227	-0.4%	-$4.98K	0.66%	76
2022 Q4	$1.24M	Sell	60,824 -430	-0.7%	-$10.8K	0.63%	79
2022 Q3	$1.57M	Sell	61,254 -22,564	-27%	-$604K	0.86%	54
2022 Q2	$1.99M	Sell	83,818 -149	-0.2%	-$3.25K	1.05%	44
2022 Q1	$1.89M	Sell	83,967 -441	-0.5%	-$9.38K	0.88%	55
2021 Q4	$1.67M	Sell	84,408 -15	-0%	-$304	0.69%	73
2021 Q3	$1.66M	Sell	84,423 -22,515	-21%	-$471K	0.75%	69
2021 Q2	$2.35M	Sell	106,938 -3,574	-3%	-$79.5K	0.8%	63
2021 Q1	$2.63M	Sell	110,512 -1,127	-1%	-$30.1K	0.87%	53
2020 Q4	$2.92M	Sell	111,639 -1,159	-1%	-$24.4K	1.11%	44
2020 Q3	$1.96M	Buy	112,798 +21,938	+24%	+$350K	0.94%	53
2020 Q2	$1.53M	Buy	+90,860	New	+$1.28M	0.7%	68